https://www.selleckchem.com/pr....oducts/emricasan-idn
BACKGROUND Metabolic disorders, including insulin resistance, obesity, and hyperlipidemia occur frequently prior to hyperglycemia in patients with type 2 diabetes mellitus (T2DM) and cause mild cognitive impairment (MCI). OBJECTIVE We investigated the involvement of resistin in these metabolic abnormalities contributes to MCI in patients with T2DM. METHODS A total of 138 hospitalized patients with T2DM were enrolled and categorized into MCI and non-MCI groups according to the Montreal Cognitive Assessment (MoCA) s
Gefällt mir
Kommentar
Teilen
